Befektetés 15 február 2026 - 16 március 2026

Reckitt Benckiser Share Price Jumps After Morgan Stanley Upgrade as Investors Revisit Selloff
···

A Reckitt Benckiser részvényárfolyama megugrik a Morgan Stanley felminősítése után, ahogy a befektetők újraértékelik az eladási hullámot

Reckitt Benckiser shares rose 2.4% to 5,484p Monday after Morgan Stanley raised its rating and set a 6,300p target, but the gain only partially offset a 15.8% monthly drop. The company launched the third phase of its £1 billion buyback on March 9. FTSE 100 closed up 0.6%. Risks remain from weak demand in Europe, tax and FX impacts, and lingering costs after asset sales.
március 17, 2026
BAE Systems Stock Price Nears 52-Week High as Defence Rally Defies FTSE Selloff
···

A BAE Systems részvényárfolyama közel 52 hetes csúcson, miközben a védelmi szektor emelkedése szembemegy az FTSE esésével

BAE Systems shares rose 0.3% to 2,306 pence in late London trading Friday, extending Thursday’s 3.14% jump to a 52-week high. The FTSE 100 fell 0.3% as most sectors declined. BAE reported closing a key design review for a $1.2 billion U.S. Space Force satellite project. Oil prices stayed above $100 a barrel amid shipping disruptions in the Persian Gulf.
március 16, 2026
Rolls-Royce Stock Price Today: Shares Slip Despite Moody’s A3 Upgrade and £7bn-£9bn Buyback Plan
···

Rolls-Royce részvényárfolyam ma: Az árfolyam csökken, annak ellenére, hogy a Moody’s A3-ra minősítette és 7-9 milliárd fontos visszavásárlási tervet jelentettek be

Rolls-Royce shares fell 1.83% to around 1,260 pence by 13:03 GMT Friday, despite Moody’s upgrading its credit rating to A3. The company forecasts £4.0–4.2 billion operating profit and £3.6–3.8 billion free cash flow for 2026, with a £7–9 billion buyback planned through 2028. Rolls-Royce warned of a £150–200 million cash flow hit in 2026 from supply chain issues.
március 14, 2026
Why SLS stock is jumping premarket: SELLAS Life Sciences puts REGAL Phase 3 countdown back in play
···

Miért ugrik az SLS részvény az előpiacon: a SELLAS Life Sciences újraindítja a REGAL 3. fázisú visszaszámlálást

SELLAS Life Sciences rose 3.4% to $4.29 in premarket trading Monday after closing at $4.15 Friday on heavy volume. Traders are watching for results from its phase 3 AML trial, with final survival data expected by mid-March. Short interest stands at 41.3 million shares, about 24% of float. SELLAS reported $71.8 million in cash at year-end.
február 24, 2026
Oracle stock price slides 5% after OpenAI’s $600 billion compute plan surfaces; ORCL traders eye Nvidia next
···

Az Oracle részvényei 5%-ot estek az OpenAI 600 milliárd dolláros számítási terve után; az ORCL kereskedők következő célpontja az Nvidia

Oracle shares fell 5.4% to $148.08 in after-hours trading Friday, underperforming a rising U.S. market. Investors focused on soaring AI infrastructure costs after reports on OpenAI’s spending. Oracle plans to raise $45–50 billion in 2026 to expand its cloud business. Nvidia is expected to report earnings February 25.
február 21, 2026
AST SpaceMobile’s $1 billion deal jolts space stocks before holiday; defense names hold up
···

Az AST SpaceMobile 1 milliárd dolláros üzlete megrázza az űripari részvényeket az ünnep előtt; a védelmi cégek tartják magukat

AST SpaceMobile shares fell 15.17% Thursday after the company announced a $1 billion convertible bond deal, then edged up 0.35% Friday. The drop hit other space stocks, while U.S. defense giants gained as Treasury yields fell on softer inflation data. U.S. markets will close Monday for Presidents Day. Investors face a long weekend to assess new financing moves and interest rate signals.
február 15, 2026